Michael S. Aberman, SVP Strategy Investor Relation at REGENERON PHARMACEUTICALS INC (REGN), sold 2,538 shares at $525.21 ($1.3M) on 2017-06-22, disclosed to the SEC on 2017-06-23.
Open-market sale of $1.3M REGN by SVP Strategy Investor Relation. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $525.21 | 395 | $207K | 15.4% |
| 2 | $525.21 | 395 | $207K | 15.4% |
| 3 | $531.51 | 274 | $146K | 10.8% |
| 4 | $531.51 | 274 | $146K | 10.8% |
| 5 | $532.27 | 200 | $106K | 7.9% |
| 6 | $533.48 | 200 |
| $107K |
| 7.9% |
| 7 | $534.51 | 200 | $107K | 7.9% |
| 8 | $536.52 | 400 | $215K | 15.9% |
| 9 | $538.30 | 100 | $54K | 4.0% |
| 10 | $541.00 | 100 | $54K | 4.0% |
| Total | $531.43 avg | 2,538 | $1.3M | 100% |
| Filing → |
| REGN | SELL | 2015-03-25 | $2.3M | — | Filing → |
| REGN | SELL | 2015-03-19 | $1.6M | — | Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |